FDA Import Refusal SCS-9474070-2/11/1 — Sanofi Aventis Spa
The FDA refused shipment SCS-9474070-2/11/1 from Sanofi Aventis Spa (Italy) on Jun 15, 2020. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 15, 2020
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 62LDY29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75